Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 503

1.
2.

Codon 12 and codon 13 mutations at the K-ras gene induce different soft tissue sarcoma types in nude mice.

Guerrero S, Figueras A, Casanova I, Farré L, Lloveras B, Capellà G, Trias M, Mangues R.

FASEB J. 2002 Oct;16(12):1642-4. Epub 2002 Aug 7.

PMID:
12207005
3.

Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.

Rusyn EV, Reynolds ER, Shao H, Grana TM, Chan TO, Andres DA, Cox AD.

Oncogene. 2000 Sep 28;19(41):4685-94.

4.
5.

Human intestinal epithelial crypt cell survival and death: Complex modulations of Bcl-2 homologs by Fak, PI3-K/Akt-1, MEK/Erk, and p38 signaling pathways.

Harnois C, Demers MJ, Bouchard V, Vallée K, Gagné D, Fujita N, Tsuruo T, Vézina A, Beaulieu JF, Côté A, Vachon PH.

J Cell Physiol. 2004 Feb;198(2):209-22.

PMID:
14603523
6.

Cell adhesion and the integrin-linked kinase regulate the LEF-1 and beta-catenin signaling pathways.

Novak A, Hsu SC, Leung-Hagesteijn C, Radeva G, Papkoff J, Montesano R, Roskelley C, Grosschedl R, Dedhar S.

Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4374-9.

7.

Induction of postmitotic neuroretina cell proliferation by distinct Ras downstream signaling pathways.

Peyssonnaux C, Provot S, Felder-Schmittbuhl MP, Calothy G, Eychène A.

Mol Cell Biol. 2000 Oct;20(19):7068-79.

8.

Opposite effects of Ha-Ras and Ki-Ras on radiation-induced apoptosis via differential activation of PI3K/Akt and Rac/p38 mitogen-activated protein kinase signaling pathways.

Choi JA, Park MT, Kang CM, Um HD, Bae S, Lee KH, Kim TH, Kim JH, Cho CK, Lee YS, Chung HY, Lee SJ.

Oncogene. 2004 Jan 8;23(1):9-20.

PMID:
14712206
9.
10.

The P34G mutation reduces the transforming activity of K-Ras and N-Ras in NIH 3T3 cells but not of H-Ras.

Oliva JL, Zarich N, Martínez N, Jorge R, Castrillo A, Azañedo M, García-Vargas S, Gutiérrez-Eisman S, Juarranz A, Boscá L, Gutkind JS, Rojas JM.

J Biol Chem. 2004 Aug 6;279(32):33480-91. Epub 2004 Jun 4.

11.
14.

Mutational and nonmutational activation of p21ras in rat colonic azoxymethane-induced tumors: effects on mitogen-activated protein kinase, cyclooxygenase-2, and cyclin D1.

Bissonnette M, Khare S, von Lintig FC, Wali RK, Nguyen L, Zhang Y, Hart J, Skarosi S, Varki N, Boss GR, Brasitus TA.

Cancer Res. 2000 Aug 15;60(16):4602-9.

15.

Novel colon cancer cell lines leading to better understanding of the diversity of respective primary cancers.

Vécsey-Semjén B, Becker KF, Sinski A, Blennow E, Vietor I, Zatloukal K, Beug H, Wagner E, Huber LA.

Oncogene. 2002 Jul 11;21(30):4646-62.

16.

K-ras Asp12 mutant neither interacts with Raf, nor signals through Erk and is less tumorigenic than K-ras Val12.

Céspedes MV, Sancho FJ, Guerrero S, Parreño M, Casanova I, Pavón MA, Marcuello E, Trias M, Cascante M, Capellà G, Mangues R.

Carcinogenesis. 2006 Nov;27(11):2190-200. Epub 2006 May 5.

PMID:
16679305
17.
18.

K-Ras and H-Ras activation promote distinct consequences on endometrial cell survival.

Ninomiya Y, Kato K, Takahashi A, Ueoka Y, Kamikihara T, Arima T, Matsuda T, Kato H, Nishida J, Wake N.

Cancer Res. 2004 Apr 15;64(8):2759-65.

19.
20.

[Mutations of growth factor receptor Flt3 in acute myeloid leukemia: transformation of myeloid cells by Ras-dependent and Ras-independent mechanisms].

Müller-Tidow C, Steur C, Mizuki M, Schwäble J, Brandts C, Berdel WE, Serve H.

Dtsch Med Wochenschr. 2002 Oct 18;127(42):2195-200. German.

PMID:
12397548

Supplemental Content

Support Center